Key result
Akt2 phosphorylates and stabilizes ATP7A to restore SOD3 activity against diabetic endothelial dysfunction.
Answers are grounded in this paper and cite their sources.
Objective— Copper transporter ATP7A (copper-transporting/ATPase) is required for full activation of SOD3 (extracellular superoxide dismutase), which is secreted from vascular smooth muscle cells (VSMCs) and anchors to endothelial cell surface to preserve endothelial function by scavenging extracellular superoxide. We reported that ATP7A protein expression and SOD3 activity are decreased in insulin-deficient type 1 diabetes mellitus vessels, thereby, inducing superoxide-mediated endothelial dysfunction, which are rescued by insulin treatment. However, it is unknown regarding the mechanism by which insulin increases ATP7A expression in VSMCs and whether ATP7A downregulation is observed in T2DM (type2 diabetes mellitus) mice and human in which insulin–Akt (protein kinase B) pathway is selectively impaired. Approach and Results— Here we show that ATP7A protein is markedly downregulated in vessels isolated from T2DM patients, as well as those from high-fat diet–induced or db/db T2DM mice. Akt2 (protein kinase B beta) activated by insulin promotes ATP7A stabilization via preventing ubiquitination/degradation as well as translocation to plasma membrane in VSMCs, which contributes to activation of SOD3 that protects against T2DM-induced endothelial dysfunction. Downregulation of ATP7A in T2DM vessels is restored by constitutive active Akt or PTP1B −/− (protein-tyrosine phosphatase 1B-deficient) T2DM mice, which enhance insulin–Akt signaling. Immunoprecipitation, in vitro kinase assay, and mass spectrometry analysis reveal that insulin stimulates Akt2 binding to ATP7A to induce phosphorylation at Ser1424/1463/1466. Furthermore, SOD3 activity is reduced in Akt2 −/− vessels or VSMCs, which is rescued by ATP7A overexpression. Conclusion— Akt2 plays a critical role in ATP7A protein stabilization and translocation to plasma membrane in VSMCs, which contributes to full activation of vascular SOD3 that protects against endothelial dysfunction in T2DM.
No takes yet. Share an insight, caveat, or question.
Varadarajan et al. (2018) studied Type 2 diabetes mellitus and endothelial dysfunction. Insulin-stimulated Akt2 activation vs. Impaired insulin-Akt signaling (T2DM or Akt2-/- vessels/VSMCs) was evaluated on ATP7A protein stabilization, plasma membrane translocation, and vascular SOD3 activation. Insulin-activated Akt2 binds and phosphorylates ATP7A at Ser1424/1463/1466 to stabilize ATP7A in vascular smooth muscle cells, restoring SOD3 activity against T2DM endothelial dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: